183 related articles for article (PubMed ID: 34225017)
21. Cell-specific discrimination of desmosterol and desmosterol mimetics confers selective regulation of LXR and SREBP in macrophages.
Muse ED; Yu S; Edillor CR; Tao J; Spann NJ; Troutman TD; Seidman JS; Henke A; Roland JT; Ozeki KA; Thompson BM; McDonald JG; Bahadorani J; Tsimikas S; Grossman TR; Tremblay MS; Glass CK
Proc Natl Acad Sci U S A; 2018 May; 115(20):E4680-E4689. PubMed ID: 29632203
[TBL] [Abstract][Full Text] [Related]
22. Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics.
Li N; Wang X; Xu Y; Lin Y; Zhu N; Liu P; Lu D; Si S
Mol Pharmacol; 2017 Apr; 91(4):264-276. PubMed ID: 28087808
[TBL] [Abstract][Full Text] [Related]
23. Identification of a gene variant in the master regulator of lipid metabolism SREBP-1 in a family with a novel form of severe combined hypolipidemia.
Kotzka J; Knebel B; Janssen OE; Schaefer JR; Soufi M; Jacob S; Nitzgen U; Muller-Wieland D
Atherosclerosis; 2011 Sep; 218(1):134-43. PubMed ID: 21645898
[TBL] [Abstract][Full Text] [Related]
24. Does changing androgen receptor status during prostate cancer development impact upon cholesterol homeostasis?
Krycer JR; Brown AJ
PLoS One; 2013; 8(1):e54007. PubMed ID: 23320115
[TBL] [Abstract][Full Text] [Related]
25. Selective Estrogen Receptor Modulators (SERMs) Synergize with Cisplatin, Induce Apoptosis and Suppress Cellular Migration and Colony Formation of Lung Cancer Cells.
Alsous L; Bardaweel S
Anticancer Agents Med Chem; 2022; 22(9):1826-1836. PubMed ID: 35546505
[TBL] [Abstract][Full Text] [Related]
26. Hypolipidemic action of the SERM acolbifene is associated with decreased liver MTP and increased SR-BI and LDL receptors.
Lemieux C; Gélinas Y; Lalonde J; Labrie F; Cianflone K; Deshaies Y
J Lipid Res; 2005 Jun; 46(6):1285-94. PubMed ID: 15741653
[TBL] [Abstract][Full Text] [Related]
27. The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer.
Howell SJ; Johnston SR; Howell A
Best Pract Res Clin Endocrinol Metab; 2004 Mar; 18(1):47-66. PubMed ID: 14687597
[TBL] [Abstract][Full Text] [Related]
28. Use of SERMs for treatment in postmenopausal women.
Pinkerton JV; Thomas S
J Steroid Biochem Mol Biol; 2014 Jul; 142():142-54. PubMed ID: 24373794
[TBL] [Abstract][Full Text] [Related]
29. Effect of Genistein on Cholesterol Metabolism-Related Genes in HepG2 Cell.
Lu R; Zheng Z; Yin Y; Jiang Z
J Food Sci; 2019 Aug; 84(8):2330-2336. PubMed ID: 31313321
[TBL] [Abstract][Full Text] [Related]
30. Lasofoxifene: a new type of selective estrogen receptor modulator for the treatment of osteoporosis.
Gennari L
Drugs Today (Barc); 2006 Jun; 42(6):355-67. PubMed ID: 16845439
[TBL] [Abstract][Full Text] [Related]
31. The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells.
Chang BY; Kim SA; Malla B; Kim SY
Toxicol Res; 2011 Jun; 27(2):85-93. PubMed ID: 24278556
[TBL] [Abstract][Full Text] [Related]
32. Reduced VLDL clearance in Apoe(-/-)Npc1(-/-) mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels.
Ishibashi M; Masson D; Westerterp M; Wang N; Sayers S; Li R; Welch CL; Tall AR
J Lipid Res; 2010 Sep; 51(9):2655-63. PubMed ID: 20562239
[TBL] [Abstract][Full Text] [Related]
33. Hepatic TRAP80 selectively regulates lipogenic activity of liver X receptor.
Kim GH; Oh GS; Yoon J; Lee GG; Lee KU; Kim SW
J Clin Invest; 2015 Jan; 125(1):183-93. PubMed ID: 25437875
[TBL] [Abstract][Full Text] [Related]
34. Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRα expression and cholesterol homeostasis.
Adlakha YK; Khanna S; Singh R; Singh VP; Agrawal A; Saini N
Cell Death Dis; 2013 Aug; 4(8):e780. PubMed ID: 23990020
[TBL] [Abstract][Full Text] [Related]
35. Selective estrogen receptor modulators: an update on recent clinical findings.
Shelly W; Draper MW; Krishnan V; Wong M; Jaffe RB
Obstet Gynecol Surv; 2008 Mar; 63(3):163-81. PubMed ID: 18279543
[TBL] [Abstract][Full Text] [Related]
36. Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms.
Yu B; Dietz BM; Dunlap T; Kastrati I; Lantvit DD; Overk CR; Yao P; Qin Z; Bolton JL; Thatcher GR
Mol Cancer Ther; 2007 Sep; 6(9):2418-28. PubMed ID: 17876041
[TBL] [Abstract][Full Text] [Related]
37. Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention.
Park WC; Jordan VC
Trends Mol Med; 2002 Feb; 8(2):82-8. PubMed ID: 11815274
[TBL] [Abstract][Full Text] [Related]
38. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta.
Repa JJ; Liang G; Ou J; Bashmakov Y; Lobaccaro JM; Shimomura I; Shan B; Brown MS; Goldstein JL; Mangelsdorf DJ
Genes Dev; 2000 Nov; 14(22):2819-30. PubMed ID: 11090130
[TBL] [Abstract][Full Text] [Related]
39. The immune activity of selective estrogen receptor modulators is gene and macrophage subtype-specific yet converges on Il1b downregulation.
Sfogliarini C; Pepe G; Cesta CM; Allegretti M; Locati M; Vegeto E
Biomed Pharmacother; 2023 Sep; 165():115008. PubMed ID: 37442065
[TBL] [Abstract][Full Text] [Related]
40. [Next generation selective estrogen receptor modulators].
Chaki O
Clin Calcium; 2006 Jan; 16(1):145-52. PubMed ID: 16397365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
